2.23
price up icon5.69%   0.12
after-market Handel nachbörslich: 2.25 0.02 +0.90%
loading
Schlusskurs vom Vortag:
$2.11
Offen:
$2.15
24-Stunden-Volumen:
2.46M
Relative Volume:
1.06
Marktkapitalisierung:
$310.99M
Einnahmen:
$288.95M
Nettoeinkommen (Verlust:
$-119.03M
KGV:
-2.4764
EPS:
-0.9005
Netto-Cashflow:
$60.67M
1W Leistung:
+6.70%
1M Leistung:
+0.45%
6M Leistung:
-58.16%
1J Leistung:
-68.46%
1-Tages-Spanne:
Value
$2.08
$2.24
1-Wochen-Bereich:
Value
$2.00
$2.24
52-Wochen-Spanne:
Value
$1.665
$10.03

Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile

Name
Firmenname
Maravai Lifesciences Holdings Inc
Name
Telefon
(858) 546-0004
Name
Adresse
10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO
Name
Mitarbeiter
580
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-18
Name
Neueste SEC-Einreichungen
Name
MRVI's Discussions on Twitter

Vergleichen Sie MRVI mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
MRVI
Maravai Lifesciences Holdings Inc
2.23 310.99M 288.95M -119.03M 60.67M -0.9005
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
450.27 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
522.27 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.00 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
568.06 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
266.80 28.51B 3.81B -644.79M -669.77M -6.24

Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-02-26 Herabstufung Robert W. Baird Outperform → Neutral
2024-12-19 Eingeleitet Guggenheim Neutral
2024-12-05 Herabstufung Goldman Neutral → Sell
2024-11-14 Eingeleitet Wolfe Research Peer Perform
2024-11-08 Herabstufung William Blair Outperform → Mkt Perform
2024-08-28 Eingeleitet Wells Fargo Overweight
2024-08-13 Herabstufung Morgan Stanley Overweight → Equal-Weight
2024-04-10 Eingeleitet Craig Hallum Buy
2023-12-12 Hochstufung BofA Securities Neutral → Buy
2023-08-08 Herabstufung KeyBanc Capital Markets Overweight → Sector Weight
2023-05-23 Herabstufung Credit Suisse Outperform → Neutral
2023-05-09 Herabstufung Goldman Buy → Neutral
2023-01-05 Herabstufung UBS Buy → Neutral
2022-12-14 Eingeleitet Deutsche Bank Buy
2022-12-07 Eingeleitet RBC Capital Mkts Outperform
2022-11-03 Herabstufung BofA Securities Buy → Neutral
2022-08-25 Eingeleitet Credit Suisse Outperform
2021-08-05 Fortgesetzt Credit Suisse Outperform
2020-12-16 Eingeleitet KeyBanc Capital Markets Overweight
2020-12-15 Eingeleitet BofA Securities Buy
2020-12-15 Eingeleitet Credit Suisse Outperform
2020-12-15 Eingeleitet Goldman Buy
2020-12-15 Eingeleitet Jefferies Buy
2020-12-15 Eingeleitet Robert W. Baird Outperform
2020-12-15 Eingeleitet Stifel Buy
2020-12-15 Eingeleitet William Blair Outperform
2020-12-14 Eingeleitet UBS Buy
Alle ansehen

Maravai Lifesciences Holdings Inc Aktie (MRVI) Neueste Nachrichten

pulisher
Jun 17, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire

Jun 17, 2025
pulisher
Jun 16, 2025

SG Americas Securities LLC Acquires 662,861 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World

Jun 16, 2025
pulisher
Jun 14, 2025

Maravai LifeSciences appoints Bernd Brust as CEO - MSN

Jun 14, 2025
pulisher
Jun 12, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Investors to Reach Out - ACCESS Newswire

Jun 12, 2025
pulisher
Jun 12, 2025

Investors Purchase Large Volume of Put Options on Maravai LifeSciences (NASDAQ:MRVI) - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

MRVI Set to Host Global Bioproduction Conference Call | MRVI Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 10, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Reach Out - ACCESS Newswire

Jun 10, 2025
pulisher
Jun 10, 2025

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Recommendation of “Hold” by Analysts - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

Maravai LifeSciences names Bernd Brust as new CEO By Investing.com - Investing.com South Africa

Jun 09, 2025
pulisher
Jun 09, 2025

Maravai Lifesciences Appoints Bernd Brust As CEO & Member Of Its Board Of Directors - MarketScreener

Jun 09, 2025
pulisher
Jun 09, 2025

Maravai LifeSciences Names Bernd Brust as CEO - marketscreener.com

Jun 09, 2025
pulisher
Jun 09, 2025

Maravai LifeSciences (MRVI) Names Bernd Brust as New CEO | MRVI Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Maravai Lifesciences Appoints Bernd Brust as New CEO - TipRanks

Jun 09, 2025
pulisher
Jun 09, 2025

Maravai LifeSciences Appoints Bernd Brust as Chief Executive Off - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Maravai LifeSciences names Bernd Brust as new CEO - Investing.com Australia

Jun 09, 2025
pulisher
Jun 09, 2025

Maravai LifeSciences Appoints Bernd Brust as Chief Executive Officer and Member of its Board of Directors | MRVI Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Maravai LifeSciences Appoints Bernd Brust as Chief Executive Officer and Member of its Board of Directors - GlobeNewswire

Jun 09, 2025
pulisher
Jun 09, 2025

Life Sciences Leader Maravai Taps Industry Veteran Bernd Brust as CEO to Accelerate Growth in Genomic Medicine - Stock Titan

Jun 09, 2025
pulisher
Jun 09, 2025

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Shares Sold by Two Sigma Investments LP - Defense World

Jun 09, 2025
pulisher
Jun 09, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $1.37 Million Position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World

Jun 09, 2025
pulisher
Jun 08, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Connect - ACCESS Newswire

Jun 08, 2025
pulisher
Jun 08, 2025

Maravai LifeSciences (NASDAQ:MRVI) Stock Price Up 8.5% – Time to Buy? - Defense World

Jun 08, 2025
pulisher
Jun 08, 2025

Jane Street Group LLC Cuts Stake in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World

Jun 08, 2025
pulisher
Jun 05, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Reach Out - ACCESS Newswire

Jun 05, 2025
pulisher
Jun 04, 2025

Quantoom Biosciences and TriLink BioTechnologies Sign a Supply and License Agreement - Insider Monkey

Jun 04, 2025
pulisher
Jun 03, 2025

TriLink and Quantoom partner to expand global vaccine access By Investing.com - Investing.com South Africa

Jun 03, 2025
pulisher
Jun 03, 2025

MRVI: TriLink BioTechnologies Partners with Quantoom for Enhanced mRNA Production | MRVI Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

TriLink and Quantoom partner to expand global vaccine access - Investing.com Australia

Jun 03, 2025
pulisher
Jun 03, 2025

Maravai's TriLink, Quantoom Sign License, Supply Agreement - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Leading COVID-19 Vaccine Technology CleanCap Expands Global Access Through Quantoom Partnership - Stock Titan

Jun 03, 2025
pulisher
May 30, 2025

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Stock Holdings Cut by Bank of America Corp DE - Defense World

May 30, 2025
pulisher
May 30, 2025

ProShare Advisors LLC Raises Stock Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World

May 30, 2025
pulisher
May 29, 2025

Maravai LifeSciences Announces Shareholder Meeting Results - Investing.com Australia

May 29, 2025
pulisher
May 29, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

May 29, 2025
pulisher
May 29, 2025

Maravai LifeSciences Sees Unusually Large Options Volume (NASDAQ:MRVI) - Defense World

May 29, 2025
pulisher
May 28, 2025

Maravai Lifesciences Holds Annual Shareholders Meeting - TipRanks

May 28, 2025
pulisher
May 28, 2025

Maravai LifeSciences Announces Shareholder Meeting Results By Investing.com - Investing.com Canada

May 28, 2025
pulisher
May 27, 2025

BNP Paribas Financial Markets Purchases Shares of 66,443 Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World

May 27, 2025
pulisher
May 22, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

May 22, 2025
pulisher
May 21, 2025

CORRECTION -- Maravai LifeSciences Releases 2024 Sustainability Report | MRVI Stock News - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Maravai LifeSciences Releases 2024 Sustainability Report Highlighting Product Innovation, Governance Enhancements, and Commitment to Sustainable Growth - Nasdaq

May 21, 2025
pulisher
May 21, 2025

CORRECTIONMaravai LifeSciences Releases 2024 Sustainability Report - The Manila Times

May 21, 2025
pulisher
May 21, 2025

CORRECTION – Maravai LifeSciences Releases 2024 Sustainability Report - GlobeNewswire

May 21, 2025
pulisher
May 21, 2025

Maravai Sustainability Report: 10x Manufacturing Expansion Plus Major Green Energy Milestones - Stock Titan

May 21, 2025
pulisher
May 21, 2025

Maravai LifeSciences Releases 2024 Sustainability Report - GlobeNewswire

May 21, 2025
pulisher
May 21, 2025

Maravai LifeSciencesReleases 2024 Sustainability Report - The Manila Times

May 21, 2025
pulisher
May 21, 2025

Maravai LifeSciences Sustainability Report: 49 New Products and 10X GMP Manufacturing Expansion Drive Growth - Stock Titan

May 21, 2025
pulisher
May 21, 2025

Northern Trust Corp Buys 53,474 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World

May 21, 2025
pulisher
May 20, 2025

Revolutionary mRNA Synthesis Kit Achieves 2X Yield, 85% Lower dsRNA: TriLink's Game-Changing Launch - Stock Titan

May 20, 2025
pulisher
May 16, 2025

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Consensus Recommendation of “Hold” by Brokerages - Defense World

May 16, 2025
pulisher
May 15, 2025

Maravai LifeSciences Q1 2025 Earnings Call: Growth Amid Challenges - TipRanks

May 15, 2025

Finanzdaten der Maravai Lifesciences Holdings Inc-Aktie (MRVI)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.74
price up icon 0.29%
$36.14
price up icon 2.09%
$20.92
price up icon 2.60%
$105.90
price up icon 0.46%
$105.09
price up icon 2.02%
biotechnology ONC
$266.80
price up icon 3.61%
Kapitalisierung:     |  Volumen (24h):